SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Getman who wrote (159)4/18/1997 3:28:00 PM
From: Xingbo Wang   of 305
 
I think they are doing the right thing in concentrating on the Allervax program. With limited cash on hand, you don't want to get your hands on too many things. However, I would fully support them to continue the other programs IF they can find corporate partners to pay all or major part of the clinical developement costs.

The last thing I wan to see is for them to try to raise more money by selling more stock. With the negative sentiment on the entire biotech sector, we would face some very serious dilutions.

Xingbo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News